EC’s proposed pharma reforms spark industry discontent
This blog explores the key areas of concern for pharmaceutical companies and some of the potential implications of these reforms.
Pricing and Market Access
Economic unrest results in an average pharmaceutical price trend of 1,123% in Lebanon
Brazilian federal court denies semaglutide patent extension
Over 2,000 drugs in Japan undergo an average price reduction of 9.4% in April
Comparison of Humira biosimilars in the US and Europe
Economic unrest results in an average pharmaceutical price trend of 1,123% in Lebanon
Colombian healthcare reform aims to upend insurance and shift focus to primary care
Risk-sharing agreements are growing at a rate of 24%
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
